アラキドン酸市場：形態、供給源、用途別-2025-2030年の世界予測

アラキドン酸市場は、2023年に2億2,667万米ドルと評価され、2024年には2億3,746万米ドルに達すると予測され、CAGR 4.62％で成長し、2030年には3億1,112万米ドルに達すると予測されています。

アラキドン酸（AA）は多価不飽和オメガ6脂肪酸で、細胞内シグナル伝達に重要であり、炎症反応と免疫系機能に不可欠なプロスタグランジンとロイコトリエンの生合成の前駆体です。乳幼児の栄養補給に欠かせない成分であり、認知機能や身体能力の向上を目的としたサプリメントに配合される可能性がますます高まっています。栄養補助食品、機能性食品、医薬品に不可欠です。これらの分野での需要の高まりは、健康志向の高まりと慢性疾患の有病率の上昇に後押しされており、より健康的なライフスタイルをサポートするためにAAを強化した製品の消費が促進されています。さらに、化粧品業界は、皮膚のバリア機能を改善し、炎症を抑えるなど、スキンケア用途におけるAAの潜在的な利点を追求しています。

市場の成長には、AAに関連する健康効果に対する意識の高まり、抽出・合成技術の進歩、AAの治療可能性に関する調査の増加といった要因が影響しています。しかし、厳しい規制の枠組み、過剰摂取による副作用の可能性、代替健康サプリメントとの競合といった課題が成長を制限しています。また、市場はサプライチェーンの混乱や生産コストの高さにも直面しています。潜在的なビジネスチャンスを生かすため、利害関係者は栄養補助食品におけるAAの用途拡大に投資し、他の生物活性化合物との相乗効果を探って新たな製剤を開発すべきです。技術革新は、持続可能な抽出技術と生物学的利用能の向上に向けることができます。臨床試験を支援するための研究機関との協力は、健康強調表示を立証し、新市場を開拓する可能性があります。

事業成長のためには、認知度が急速に向上し、個別化栄養トレンドが浸透しつつある新興国市場での用途開発に注力すべきです。成功のためには、現地の規制環境や消費者の嗜好を理解することが重要です。イノベーションはまた、コスト削減のために拡張性を向上させ、環境意識の高い消費者にアピールするために環境にやさしい実践を促進することを目指すべきです。全体として、AAの市場はダイナミックであり、製品の差別化と市場セグメンテーションの進展に十分な機会があります。

市場力学：急速に進化するアラキドン酸市場の主要市場インサイトを公開

アラキドン酸市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ベビーケア製品に関する消費者意識の高まり
  • 重篤な身体損傷を治癒するための製品需要の増加
  • 乳児栄養における油性ARA製品に対する規制当局の受け入れ拡大
• 市場抑制要因
  • 規制当局による厳しい規制と品質基準
• 市場機会
  • 社内製造技術の向上に注力する新興企業
  • 製品の品質とブランド価値を高めるための継続的な研究開発活動
• 市場の課題
  • 副作用とアレルギー反応

ポーターのファイブフォース：アラキドン酸市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：アラキドン酸市場における外部からの影響の把握

外部マクロ環境要因は、アラキドン酸市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析アラキドン酸市場における競合情勢の把握

アラキドン酸市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスアラキドン酸市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、アラキドン酸市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨アラキドン酸市場における成功への道筋を描く

アラキドン酸市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ベビーケア製品に関する消費者の意識の高まり
    • 重篤な身体的損傷を治療するための製品需要の増加
    • 乳児栄養における油性ARA製品の規制承認の拡大
  • 抑制要因
    • 規制当局によって課せられる厳しい規制と品質基準
  • 機会
    • 社内の製造技術の向上に注力する新興企業
    • 製品の品質とブランド価値を高めるための継続的な研究開発活動
  • 課題
    • 副作用とアレルギー反応
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 アラキドン酸市場：形態別

• ドライ
• 液体

第7章 アラキドン酸市場：ソース別

• 動物由来
• 微生物由来

第8章 アラキドン酸市場：用途別

• 動物栄養
• 化粧品
• 栄養補助食品
• 食品・飲料
• 乳児用調製粉乳
• 医薬品

第9章 南北アメリカのアラキドン酸市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のアラキドン酸市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのアラキドン酸市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Ataman Kimya A.S
• BASF SE
• BioCrick Co., Ltd.
• Biosynth
• CABIO Biotech（Wuhan）Co., Ltd.
• Cargill, Inc.
• Cayman Chemical Company
• Central Drug House Pvt. Ltd.
• Croda International PLC
• Enzo Biochem
• Koninklijke DSM N.V.
• Merck KgaA
• MP Biomedicals
• Santa Cruz Biotechnology, Inc.
• Sisco Research Laboratories Pvt. Ltd.
• Suntory Group
• Tokyo Chemical Industry Co., Ltd.

LIST OF FIGURES

• FIGURE 1. ARACHIDONIC ACID MARKET RESEARCH PROCESS
• FIGURE 2. ARACHIDONIC ACID MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARACHIDONIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ARACHIDONIC ACID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ARACHIDONIC ACID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ARACHIDONIC ACID MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ARACHIDONIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARACHIDONIC ACID MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARACHIDONIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARACHIDONIC ACID MARKET DYNAMICS
• TABLE 7. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY DRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY ANIMAL-DERIVED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY MICROBIAL-DERIVED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY INFANT FORMULA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ARACHIDONIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES ARACHIDONIC ACID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA ARACHIDONIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM ARACHIDONIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ARACHIDONIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM ARACHIDONIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. ARACHIDONIC ACID MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. ARACHIDONIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

The Arachidonic Acid Market was valued at USD 226.67 million in 2023, expected to reach USD 237.46 million in 2024, and is projected to grow at a CAGR of 4.62%, to USD 311.12 million by 2030.

Arachidonic Acid (AA) is a polyunsaturated omega-6 fatty acid critical in cellular signaling and as a precursor in the biosynthesis of prostaglandins and leukotrienes, which are vital for inflammatory responses and immune system function. It is a key component in infant nutrition and increasingly recognized for its potential role in supplements aimed at enhancing cognitive functions and physical performance. The necessity of AA extends across various industries; it is indispensable in dietary supplements, functional foods, and pharmaceuticals. The growing demand in these sectors is fueled by increasing health consciousness and the rising prevalence of chronic diseases, which promote the consumption of products fortified with AA to support healthier lifestyles. Furthermore, the cosmetics industry is exploring AA for its potential benefits in skincare applications, such as improving skin barrier function and reducing inflammation.

Market growth is influenced by factors like rising awareness of health benefits associated with AA, advancements in extraction and synthesis technologies, and increased research into the therapeutic potentials of AA. However, challenges such as stringent regulatory frameworks, potential side effects when consumed in excess, and competition from alternative health supplements limit growth. The market also faces supply-chain disruptions and high production costs. To capitalize on potential opportunities, stakeholders should invest in broadening AA's application in nutraceuticals and explore synergy with other bioactive compounds to develop new formulations. Innovation can be directed towards sustainable extraction techniques and enhancing bioavailability. Collaboration with research institutions to support clinical trials could substantiate health claims, thus unlocking new markets.

For business growth, companies should focus on developing applications in emerging markets where awareness is increasing rapidly, and personalized nutrition trends are gaining traction. Understanding local regulatory environments and consumer preferences is crucial for success. Innovation should also aim at improving scalability to reduce costs and promote environmentally friendly practices to appeal to eco-conscious consumers. Overall, the market for AA is dynamic, with ample opportunities for advancements in product differentiation and market segmentation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Arachidonic Acid Market

The Arachidonic Acid Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing consumer awareness related to baby care products
  • Increasing product demand to heal critical physical injuries
  • Rising regulatory acceptance for oil-based ARA products in infant nutrition
• Market Restraints
  • Strict regulations and quality standards imposed by regulatory bodies
• Market Opportunities
  • Emerging focusing on improving the in-house manufacturing techniques
  • Ongoing R&D activities to enhance product quality and brand value
• Market Challenges
  • Side effects and allergic reactions

Porter's Five Forces: A Strategic Tool for Navigating the Arachidonic Acid Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Arachidonic Acid Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Arachidonic Acid Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Arachidonic Acid Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Arachidonic Acid Market

A detailed market share analysis in the Arachidonic Acid Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Arachidonic Acid Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Arachidonic Acid Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Arachidonic Acid Market

A strategic analysis of the Arachidonic Acid Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Arachidonic Acid Market, highlighting leading vendors and their innovative profiles. These include Ataman Kimya A.S, BASF SE, BioCrick Co., Ltd., Biosynth, CABIO Biotech (Wuhan) Co., Ltd., Cargill, Inc., Cayman Chemical Company, Central Drug House Pvt. Ltd., Croda International PLC, Enzo Biochem, Koninklijke DSM N.V., Merck KgaA, MP Biomedicals, Santa Cruz Biotechnology, Inc., Sisco Research Laboratories Pvt. Ltd., Suntory Group, and Tokyo Chemical Industry Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Arachidonic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Form, market is studied across Dry and Liquid.
• Based on Source, market is studied across Animal-Derived and Microbial-Derived.
• Based on Application, market is studied across Animal Nutrition, Cosmetics, Dietary Supplements, Food & Beverages, Infant Formula, and Pharmaceuticals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing consumer awareness related to baby care products
    • 5.1.1.2. Increasing product demand to heal critical physical injuries
    • 5.1.1.3. Rising regulatory acceptance for oil-based ARA products in infant nutrition
  • 5.1.2. Restraints
    • 5.1.2.1. Strict regulations and quality standards imposed by regulatory bodies
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging focusing on improving the in-house manufacturing techniques
    • 5.1.3.2. Ongoing R&D activities to enhance product quality and brand value
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects and allergic reactions
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Arachidonic Acid Market, by Form

• 6.1. Introduction
• 6.2. Dry
• 6.3. Liquid

7. Arachidonic Acid Market, by Source

• 7.1. Introduction
• 7.2. Animal-Derived
• 7.3. Microbial-Derived

8. Arachidonic Acid Market, by Application

• 8.1. Introduction
• 8.2. Animal Nutrition
• 8.3. Cosmetics
• 8.4. Dietary Supplements
• 8.5. Food & Beverages
• 8.6. Infant Formula
• 8.7. Pharmaceuticals

9. Americas Arachidonic Acid Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Arachidonic Acid Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Arachidonic Acid Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Ataman Kimya A.S
• 2. BASF SE
• 3. BioCrick Co., Ltd.
• 4. Biosynth
• 5. CABIO Biotech (Wuhan) Co., Ltd.
• 6. Cargill, Inc.
• 7. Cayman Chemical Company
• 8. Central Drug House Pvt. Ltd.
• 9. Croda International PLC
• 10. Enzo Biochem
• 11. Koninklijke DSM N.V.
• 12. Merck KgaA
• 13. MP Biomedicals
• 14. Santa Cruz Biotechnology, Inc.
• 15. Sisco Research Laboratories Pvt. Ltd.
• 16. Suntory Group
• 17. Tokyo Chemical Industry Co., Ltd.